NASDAQ:EARS
Delisted

Auris Medical Holding AG Stock Price (Quote)

$0.750
-0.0010 (-0.133%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.680 $1.00 Friday, 27th May 2022 EARS stock ended at $0.750. This is 0.133% less than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 10.68% from a day low at $0.740 to a day high of $0.82.
90 days $0.635 $2.14
52 weeks $0.635 $4.58

Historical Auris Medical Holding AG prices

Date Open High Low Close Volume
Jun 02, 2021 $3.50 $3.82 $3.50 $3.69 513 512
Jun 01, 2021 $3.60 $3.66 $3.45 $3.53 433 894
May 28, 2021 $3.45 $3.77 $3.45 $3.59 1 403 870
May 27, 2021 $3.33 $3.52 $3.30 $3.49 547 392
May 26, 2021 $3.21 $3.37 $3.16 $3.29 429 468
May 25, 2021 $3.27 $3.30 $3.16 $3.22 266 326
May 24, 2021 $3.30 $3.36 $3.18 $3.23 277 122
May 21, 2021 $3.38 $3.54 $3.26 $3.30 1 244 798
May 20, 2021 $3.36 $3.41 $3.28 $3.33 294 201
May 19, 2021 $3.20 $3.37 $3.15 $3.36 519 740
May 18, 2021 $3.18 $3.34 $3.14 $3.25 604 491
May 17, 2021 $3.04 $3.22 $3.04 $3.20 343 010
May 14, 2021 $3.17 $3.19 $3.03 $3.11 606 300
May 13, 2021 $3.26 $3.26 $2.88 $3.01 700 848
May 12, 2021 $3.20 $3.45 $3.13 $3.21 3 313 379
May 11, 2021 $3.05 $3.26 $3.04 $3.16 504 268
May 10, 2021 $3.17 $3.35 $2.97 $3.31 2 055 189
May 07, 2021 $3.05 $4.34 $3.01 $3.35 38 735 499
May 06, 2021 $2.86 $3.06 $2.78 $2.87 1 368 227
May 05, 2021 $3.06 $3.17 $2.86 $2.90 925 056
May 04, 2021 $3.35 $3.35 $3.04 $3.17 487 656
May 03, 2021 $3.47 $3.50 $3.35 $3.42 305 271
Apr 30, 2021 $3.47 $3.67 $3.44 $3.54 320 951
Apr 29, 2021 $3.50 $3.53 $3.32 $3.52 313 040
Apr 28, 2021 $3.43 $3.50 $3.35 $3.47 384 486
Click to get the best stock tips daily for free!

About Auris Medical Holding AG

Auris Medical Holding AG Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical development for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss; and other pre-clinical stage products comprising AM-102 and AM-123. It has... EARS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT